Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Earnings release
confidence 95%
filed 2026-06-18
This 6-K furnishes the unaudited interim financial statements and management's discussion and analysis for the three months ended March 31, 2026. The exhibit includes consolidated statements of operations, comprehensive income, balance sheets, and cash flows, along with detailed MD&A discussing material changes in financial performance. This is a standard quarterly earnings disclosure material to investors assessing the registrant's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-17
Item 7.01
The Company disclosed financial results for the month and year-to-date periods ended May 31, 2026, via a news release furnished under Regulation FD.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-06-17
EX-99.1
This is a press release announcing Waterdrop Inc.'s unaudited financial results for the first quarter of 2026 (three months ended March 31, 2026). The document discloses net operating revenue of RMB1,242.2 million (up 64.8% YoY), operating profit of RMB80.0 million, and net profit attributable to ordinary shareholders of RMB98.4 million, along with detailed segment results, balance sheet, and cash flow information. This is a discrete earnings announcement, not a periodic financial report filing itself, and constitutes a material event affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-17
Item 2.02
The company issued a press release on June 17, 2026 reaffirming full-year 2026 revenue growth guidance previously provided in the first quarter earnings release, disclosed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-06-17
Item 2.02
CarMax issued a press release on June 17, 2026, announcing first quarter financial results for the period.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-17
The 6-K body contains a press release announcing Deswell's second half and full year fiscal 2026 financial results (for the year ended March 31, 2026), including net sales of $61.3 million, net income of $10.6 million, and earnings per share of $0.67. The disclosure also announces a regular cash dividend of $0.10 per share and a special cash dividend of $0.20 per share. This is a discrete earnings announcement with detailed financial statements and MD&A, not a periodic report filing itself.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-06-17
EX-99.1
This is a press release announcing 17EdTech's unaudited financial results for the first quarter of 2026, dated June 17, 2026. The exhibit discloses quarterly net revenues of RMB99.5 million (up 359% year-over-year), gross margin of 61.9%, and net loss of RMB19.4 million (down 37.4% year-over-year), along with detailed operating expense breakdowns and cash position. The disclosure includes management commentary and is accompanied by unaudited condensed consolidated financial statements and reconciliations of non-GAAP measures. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the company's operational performance and financial trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-17
Item 2.02
Item 2.02 disclosure explicitly references a press release issued on June 17, 2026, and states that textual information from that press release is being furnished in connection with "Results of Operations and Financial Condition." This is the standard format for earnings release disclosures under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-17
Item 2.02
The filing discloses Odyssey Therapeutics' financial results for the three months ended March 31, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement under Item 2.02, which is the designated Item for disclosure of results of operations and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-17
Item 2.02
The filing discloses financial and operational results for the three months and year ended March 31, 2026, with a press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, reporting quarterly and annual financial results for a public company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-17
Item 2.02
The filing discloses Jabil Inc.'s results of operations for the third fiscal quarter ended May 31, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides financial performance data essential to assessing the registrant's operational results and financial condition.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-06-17
EX-99.1
This is an announcement that ICON plc will release its first quarter 2026 financial results on June 23, 2026, followed by a conference call on June 24, 2026. While the exhibit itself is technically a scheduling notice rather than the actual earnings release, it announces the forthcoming disclosure of quarterly financial results, which is material to investors. The announcement explicitly states "it will release its financial results for the first quarter 2026" and invites participation in the earnings call, making this a material earnings-related disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-16
Item 2.02
La-Z-Boy issued a news release on June 16, 2026 reporting financial results for the fiscal quarter ended April 25, 2026, disclosing quarterly financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-16
Item 2.02
The filing discloses financial results for the first fiscal quarter ended May 2, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement under Item 2.02, which is material to investors as it provides periodic financial performance data essential to assessing the registrant's operating results and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-16
The 8-K discloses a press release issued on June 16, 2026 titled "NextBoat Inc.'s Autograph Yachts Division Delivers Strong Second Quarter Growth, Driven by Expanding Brokerage Platform and Market Share Gains." This is filed under Item 7.01 (Regulation FD Disclosure) with the press release attached as Exhibit 99.1. The language referencing "Second Quarter Growth" and performance metrics indicates this is an earnings or operational results announcement, which would be material to investors assessing the registrant's financial performance and market position.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-16
EX-99.1
This exhibit is a press release announcing Uxin's unaudited financial results for the quarter ended March 31, 2026. It discloses quarterly revenues (RMB1,073.7 million), transaction volumes (18,211 units), gross margin (7.0%), operating loss (RMB66.6 million), and net loss (RMB91.6 million), along with management commentary and forward guidance. The document explicitly states "Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026" and includes consolidated financial statements and reconciliations of non-GAAP measures, which are hallmarks of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-16
Item 2.02
California Resources Corp disclosed results of operations and financial condition for a completed fiscal period, consistent with a quarterly or annual earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-16
Item 7.01
The filing discloses a press release announcing "updated guidance for the quarter ended June 30, 2026," which constitutes forward-looking financial information material to investors' assessment of the company's expected performance. While technically disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is guidance disclosure—a form of earnings-related announcement that would affect a reasonable investor's view of the registrant's financial trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-16
Item 2.02
John Wiley & Sons disclosed financial results for the fourth quarter and fiscal year ended April 30, 2026, via press release (Exhibit 99.1) and earnings conference call presentation materials (Exhibit 99.2) held on June 16, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses quarterly financial results for the third quarter ended April 30, 2026, via a press release furnished as Exhibit 99.1 under Item 2.02. This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's operational and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses Canopy Growth Corporation's financial results for its fiscal fourth quarter ended March 31, 2026, via a press release attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly financial performance information essential to assessing the registrant's operating results and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-06-15
Item 2.02
enGene Therapeutics disclosed financial results for the three months ended April 30, 2026, including clinical and corporate updates, furnished via press release as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
Item 2.02 disclosure of a press release issued on June 12, 2026 regarding "sales and earnings for its second quarter ended May 2, 2026" is a classic earnings release. The filing explicitly references quarterly financial results and attaches the press release as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses Gencor Industries' financial results for the second quarter of fiscal 2026 via a press release issued on June 12, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly financial performance information.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-06-15
EX-99.1
This is a press release dated June 10, 2026, disclosing Scinai's first-quarter 2026 financial results (three months ended March 31, 2026), including revenues, operating loss, net income, and balance-sheet metrics. The exhibit includes condensed consolidated financial statements (balance sheet, income statement, cash flows, and changes in shareholders' equity) and a corporate update. While the release also discusses the Recipharm Israel acquisition and strategic initiatives, the primary disclosure is the quarterly financial results, which is characteristic of an earnings_release. The acquisition is presented as a completed transaction within the results narrative rather than as a discrete M&A event announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses a press release announcing financial results for fiscal year 2026 fourth quarter and full year ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-06-15
EX-99.1
This is a press release dated June 15, 2026, announcing High Tide Inc.'s second quarter 2026 financial results. The document discloses record revenue of $179.3 million (up 30% YoY), record adjusted EBITDA of $13.9 million (up 73% YoY), positive net income, and positive free cash flow. It includes detailed financial highlights, retail metrics, operational updates, and forward guidance. This is a classic earnings release announcing quarterly financial results, material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02
The filing discloses a press release issued on June 15, 2026 announcing financial results for the second quarter ended April 30, 2026. This is a classic earnings release disclosure under Item 2.02, with the press release furnished as Exhibit 99.1. Quarterly financial results are material to investors' assessment of the registrant's performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02 discloses that on June 15, 2026, Powerfleet issued a press release regarding financial results for the fourth quarter and fiscal year ended March 31, 2026, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure, and Item 7.01 further indicates a conference call to discuss these results and provide a business update. Earnings releases are material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02 discloses that on June 15, 2026, PURE Bioscience issued a press release announcing financial results for the fiscal third quarter ended April 30, 2026. The press release is attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02
The filing discloses that Dave & Buster's Entertainment issued a press release on June 15, 2026 announcing "results its first quarter 2026 results," with the press release attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly financial performance information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-06-15
Item 8.01
The Company issued a press release on June 15, 2026 announcing Phase 2 clinical trial results for ELI-002 7P in pancreatic cancer and outlining a refined Phase 3 development strategy. While this is clinical trial data rather than financial earnings, it is a material disclosure of significant clinical progress that would affect investor assessment of the Company's pipeline and development trajectory. The attachment of a press release and conference call presentation indicates this is a formal material announcement comparable in disclosure significance to an earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses financial results for the fiscal quarter and year ended April 30, 2026 via a press release attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly and annual financial performance information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02
The filing discloses financial results for Vistagen's fiscal year ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which would materially affect a reasonable investor's assessment of the company's financial performance and condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-15
Item 2.02
The filing discloses a press release announcing quarterly financial results for the period ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's financial condition and operating results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-06-15
Item 7.01
Vivakor issued a press release on June 9, 2026 disclosing the Company's first quarter 2026 financial results. The earnings announcement was furnished along with operational updates and shareholder meeting notices issued on June 10 and 11, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-12
Item 2.02
Santander Holdings USA disclosed its Q2 2026 financial results on June 12, 2026, including results of operations and financial condition for the period.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-12
EX-99.5
This exhibit is a press release announcing C21 Investments' audited financial statements and results for the fourth quarter and fiscal year ending March 31, 2026. The document discloses key financial metrics including revenue of $32.6 million (up 8.3%), gross margin of 42%, income from operations of $2.3 million (up 78%), and record customer transactions of 725,000 (up 16%). The company explicitly states it is announcing "the filing of its audited financial statements and management discussion and analysis" and provides detailed fiscal year and quarterly highlights with comparative prior-year data, which is characteristic of an earnings release rather than a periodic financial report itself.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-06-12
EX-99.1
This is a press release announcing 51Talk's unaudited financial results for the first quarter ended March 31, 2026. The exhibit discloses net revenues of US$31.2 million (70.9% YoY increase), gross billings of US$33.3 million (51.9% YoY increase), active students of 132,900 (63.9% YoY increase), and a net loss of US$2.3 million. It includes full financial statements (balance sheet, income statement, and non-GAAP reconciliations) and forward guidance for Q2 2026. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-12
Item 2.02
The filing discloses operating results for the fiscal quarter ended April 30, 2026, with a press release attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly financial performance information for a REIT.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-12
Item 2.02
IEH Corporation disclosed its financial results for fiscal year ended March 31, 2026 via press release on June 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard annual earnings release disclosure, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-12
Item 7.01
Invesco Mortgage Capital issued a press release on June 12, 2026 disclosing preliminary financial data as of May 31, 2026, including book value, portfolio composition, liquidity, and leverage metrics. The preliminary financial disclosure is material to investors assessing the mortgage REIT's portfolio performance and dividend sustainability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-12
Item 2.02
The filing discloses quarterly financial results for the period ended April 30, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02. This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information essential to assessing the registrant's operating results and financial condition.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-06-12
EX-99.1
This press release announces Phase III clinical trial results for sovleplenib (ESLIM-02 study) in warm antibody autoimmune hemolytic anemia, presented at EHA 2026 Congress. The disclosure highlights that the study met its primary endpoint with statistically significant efficacy data (66% durable response vs 15% placebo, p<0.0001) and a favorable safety profile. While this is a clinical milestone rather than financial results, it represents a material operational and regulatory event: the NMPA has accepted the NDA for priority review and granted Breakthrough Therapy Designation, positioning sovleplenib as a potential commercial product addressing an unmet medical need in a treatment-sparse landscape. The data directly supports regulatory advancement and future revenue potential.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
Adobe issued a press release on June 11, 2026 announcing financial results for Q2 fiscal year 2026 ended May 29, 2026, disclosing both GAAP and non-GAAP financial measures including revenue growth, operating income, net income, diluted EPS, operating margin, and tax rate.
View raw filing on EDGAR →
RH
(RH)
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
RH disclosed financial results for the first quarter ended May 2, 2026 via a press release and shareholder letter on June 11, 2026. This is a standard quarterly earnings release disclosed under Item 2.02, with exhibits attached containing the formal announcement and letter to shareholders. Quarterly financial results are material to investors' assessment of the registrant's performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-11
Item 2.02
Item 2.02 discloses the issuance of a press release on June 11, 2026 regarding results of operations and financial condition. This is a standard earnings release disclosure, typically material to investors as it communicates the registrant's financial performance and results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-11
Item 2.02
The filing discloses J. W. Mays, Inc.'s financial results for the three and nine months ended April 30, 2026, including revenues and net loss figures with year-over-year comparisons. A press release reporting quarterly financial results is the classic earnings_release event, and Item 2.02 is the standard disclosure location for such announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
The filing explicitly discloses an earnings release announcing "results of operations for the fiscal quarter ended April 30, 2026," distributed via wire service and posted to the company's investor relations website. The earnings release is furnished as Exhibit 99.1 under Item 2.02 of Form 8-K, which is the standard Item for quarterly financial results disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
The filing discloses results of operations for the fiscal quarter ended April 30, 2026, with a press release furnished as Exhibit 99.1 under Item 2.02. This is a standard quarterly earnings release disclosure, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →